The Relationship Between Kinesiophobia, Physical Activity, Balance and Fear of Fall in MS Patients

NCT04183751 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2020-09-04

No results posted yet for this study

Summary

Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating and neurodegenerative disease of the central nervous system (CNS). MS usually progresses with attacks, sequelae after attacks because it severely restricts the quality of life in patients and leads to progressive disability (Frohman et al., 2006). Balance and coordination problems, decreasing of physical activity level and fall disorders are observed in patients with MS (Confavreux et al., 2014). When the literature was examined, a relationship was found between kinesiophobia, quality of life, physical activity level and pain in stroke patients. Physical activity level, balance, fear of falling and kinesiophobia which are frequently seen in patients with MS have not been studied. In this study, the relationship between kinesiophobia, physical activity, balance and fear of fall in MS patients will be investigated.

Conditions

Interventions

OTHER

scale study

Forms and questionnaires will be used. The data will be collected by the researchers by face to face interview technique.

Sponsors & Collaborators

  • Marmara University

    lead OTHER

Principal Investigators

  • SEMRA OGUZ, PhD · Marmara University

  • SEDA KARACA, MsC · Marmara University

  • ELIF UNAL, Dr · Okmeydanı Hospital

  • CANAN BOLCU EMIR, Dr · Okmeydanı Hospital

  • MINE GULDEN POLAT, Prof · Marmara University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-21
Primary Completion
2020-12-21
Completion
2021-07-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04183751 on ClinicalTrials.gov